Skip to main content

and
  1. Article

    Open Access

    Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism

    Gastric cancer (GC) is among the most lethal malignancies due to its poor early diagnosis and high metastasis rate, and new therapeutic targets are urgently needed to develop effective anti-GC drugs. Glutathio...

    Handong Xu, Can Hu, Yi Wang, Yunfu Shi, Li Yuan, **gli Xu, Yanqiang Zhang in Oncogene (2023)

  2. Article

    Open Access

    CircVPRBP inhibits nodal metastasis of cervical cancer by impeding RACK1 O-GlcNAcylation and stability

    Lymph node (LN) metastasis is one of the most malignant clinical features in patients with cervical cancer (CCa). Understanding the mechanism of lymph node metastasis will provide treatment strategies for pati...

    Chunyu Zhang, Hongye Jiang, Li Yuan, Yuandong Liao, Pan Liu, Qiqiao Du in Oncogene (2023)

  3. Article

    Open Access

    EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma

    Epstein–Barr virus (EBV) was the first oncogenic virus identified in humans. It is primarily associated with multiple lymphoid and epithelial cancers, including nasopharyngeal carcinoma (NPC). However, its ass...

    Li Yuan, Shibing Li, Qiuyan Chen, Tianliang **a in Cell Death & Differentiation (2022)

  4. No Access

    Article

    Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition

    Metastatic prostate cancer (PCa) in bone induces bone-forming lesions that enhance PCa progression. How tumor-induced bone formation enhances PCa progression is not known. We have previously shown that PCa-ind...

    Yu-Chen Lee, Song-Chang Lin, Guoyu Yu, Ming Zhu, Jian H. Song, Keith Rivera in Oncogene (2022)

  5. No Access

    Article

    Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone

    A fraction of patients undergoing androgen deprivation therapy (ADT) for advanced prostate cancer (PCa) will develop recurrent castrate-resistant PCa (CRPC) in bone. Strategies to prevent CRPC relapse in bone ...

    Tianhong Pan, Song-Chang Lin, Yu-Chen Lee, Guoyu Yu, Jian H. Song, **g Pan in Oncogene (2021)

  6. Article

    Open Access

    SIRT1 attenuates renal fibrosis by repressing HIF-2α

    Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase belonging to class III histone deacetylases. Previous studies have shown that SIRT1 is involved in kidney physiology regulatio...

    Peipei Li, Yue Liu, **aogang Qin, Kairen Chen, Ruiting Wang in Cell Death Discovery (2021)

  7. No Access

    Article

    VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR

    It has been well established that the von Hippel-Lindau/hypoxia-inducible factor α (VHL-HIFα) axis and epidermal growth factor receptor (EGFR) signaling pathway play a critical role in the pathogenesis and pro...

    Cheng Liu, Li Liu, Kun Wang, **ao-Feng Li, Li-Yuan Ge, Run-Zhuo Ma, Yi-Dong Fan in Oncogene (2020)

  8. No Access

    Article

    Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein

    Microtubules play a central role in coordinating various cellular functions that are orchestrated by their interaction with molecular motors. Anticancer drugs that target microtubule dynamics have been shown t...

    Sue-Hwa Lin, Michiya Nishino, Wei** Luo, Jonathan P Aumais, Matthew Galfione in Oncogene (2004)

  9. No Access

    Article

    Developmental expression of Pim kinases suggests functions also outside of the hematopoietic system

    We have cloned a novel quail cDNA with strong homology to the pim family of proto-oncogenes. The deduced amino acid (aa) sequence of the cDNA, named qpim, is more closely related to Xenopus Pim and to the recentl...

    Anne Eichmann, Li Yuan, Christiane Bréant, Kari Alitalo, Päivi J Koskinen in Oncogene (2000)